If you suspect your patient may have rheumatoid arthritis, fibromyalgia, or lupus, the IsolateRheum panel will be available in late 2017.
Join our community to stay up-to-date on advancements with our research for this new tool and when it will be ready for use in your practice.
One Test. Many Answers.
IsolateRheum™ is a breakthrough RNA test that can rule in or rule out a suspected diagnosis of rheumatoid arthritis, fibromyalgia, or lupus in as little as seven days.
IsolateRheum gives healthcare providers a new tool to confirm suspected diagnoses much sooner than traditional testing methods. By confirming the suspected autoimmune disease faster, doctors can initiate treatment earlier in the disease progression. Earlier treatment can help slow the illness and allow better management of its long-term physical, emotional and financial effects.